Christian Voigtlander Sells 8,929 Shares of ICU Medical (NASDAQ:ICUI) Stock

ICU Medical, Inc. (NASDAQ:ICUI) COO Christian Voigtlander sold 8,929 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $182.93, for a total transaction of $1,633,381.97. Following the sale, the chief operating officer directly owned 37,377 shares in the company, valued at $6,837,374.61. The trade was a 19.28% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

ICU Medical Stock Performance

Shares of NASDAQ:ICUI traded down $0.34 during trading on Tuesday, hitting $182.08. 250,319 shares of the stock traded hands, compared to its average volume of 297,071. The company has a quick ratio of 1.21, a current ratio of 2.43 and a debt-to-equity ratio of 0.56. The company has a market cap of $4.55 billion, a price-to-earnings ratio of 154.31, a P/E/G ratio of 2.58 and a beta of 0.74. The company has a fifty day moving average price of $152.66 and a two-hundred day moving average price of $141.12. ICU Medical, Inc. has a 52-week low of $107.50 and a 52-week high of $192.85.

ICU Medical (NASDAQ:ICUI) last posted its earnings results on Thursday, August 6th. The medical instruments supplier reported $2.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.91 by $0.46. ICU Medical had a net margin of 1.39% and a return on equity of 7.91%. The firm had revenue of $547.88 million during the quarter, compared to analysts’ expectations of $533.44 million. During the same period in the previous year, the business posted $2.10 EPS. The business’s revenue was up .5% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. As a group, equities analysts predict that ICU Medical, Inc. will post 6.51 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. Piper Sandler increased their target price on shares of ICU Medical from $163.00 to $195.00 and gave the stock an “overweight” rating in a research note on Friday. Wall Street Zen upgraded ICU Medical from a “buy” rating to a “strong-buy” rating in a research note on Saturday. BTIG Research upped their price target on ICU Medical from $170.00 to $200.00 and gave the stock a “buy” rating in a report on Friday. Jefferies Financial Group upgraded ICU Medical to a “strong-buy” rating in a research report on Thursday, May 7th. Finally, Sanford C. Bernstein lowered ICU Medical to a “market perform” rating in a report on Monday, June 15th. Two equities research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, ICU Medical currently has an average rating of “Moderate Buy” and a consensus price target of $192.80.

Hedge Funds Weigh In On ICU Medical

Large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. purchased a new position in ICU Medical during the second quarter valued at $550,250,000. Vanguard Group Inc. increased its stake in shares of ICU Medical by 3.4% during the fourth quarter. Vanguard Group Inc. now owns 2,714,746 shares of the medical instruments supplier’s stock worth $387,313,000 after purchasing an additional 89,755 shares in the last quarter. Janus Henderson Group PLC raised its position in shares of ICU Medical by 3.9% during the 1st quarter. Janus Henderson Group PLC now owns 2,676,012 shares of the medical instruments supplier’s stock worth $345,607,000 after purchasing an additional 99,256 shares during the last quarter. Millennium Management LLC raised its position in shares of ICU Medical by 173.4% during the 3rd quarter. Millennium Management LLC now owns 1,089,017 shares of the medical instruments supplier’s stock worth $130,638,000 after purchasing an additional 690,694 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in ICU Medical by 6.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 983,802 shares of the medical instruments supplier’s stock valued at $127,053,000 after buying an additional 63,026 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.